Indefinite Delivery Contract SPE2DX16D9938
- Not listed
- This Indefinite Delivery Contract (IDC) award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is valued at up to $4,999,999.99 through December 31, 2025. The contract provides for the delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits...
- This Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., aims to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The single-award IDC, valued at up to $999,999,999.00, serves as the primary vehicle for delivering essential medical commodities including specialty medications, brand-name and generic...
- The federal contract IDV award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, which runs through December 31, 2025, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC encompasses critical medical commodities...
- This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at up to $4,999,999.99, spans from April 1, 2016 to December 31, 2025 and provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers a wide variety of essential medical commodities, including specialty...
- This Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is valued at up to $4,999,999.00 and runs through December 31, 2025. The contract provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The task orders under this IDC cover a variety of critical medical commodities, including...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at up to $999,999,999.00, runs through December 31, 2025 and serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contracted items include specialty...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at up to $4,999,999.00, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs,...
- The provided information describes an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The single-award IDC, valued at up to $999,999,999.00, runs through December 31, 2025 and serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. The...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at up to $4,999,999.00, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract encompasses critical...
- The Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. is a single-award contract valued at $999,999,999 through November 2026. This contract serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses a broad spectrum of critical medical commodities, including...
This federal Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a comprehensive pharmaceutical and medical supply contract valued at up to $4,999,999.99. The contract runs through December 31, 2025 and covers a wide range of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health, pain management, and infectious disease prevention. As the prime contractor, Amerisourcebergen leverages its extensive pharmaceutical distribution capabilities to efficiently fulfill delivery orders for the DLA, supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities worldwide. The contract was awarded through full and open competition without any set-aside requirements, reflecting Amerisourcebergen's strong position in the federal pharmaceutical distribution market.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 4/5/16 |